This is the product description text that will appear here.
Quantity
1
Description
Edited by Martin Kolb and Claus F. Vogelmeier The traditional end-points for clinical studies of lung diseases were based on functional parameters. Their value as surrogate markers for disease activity and progression has been increasingly q...